Literature DB >> 17457205

Topical steroids in the management of Churg-Strauss syndrome involving the conjunctiva.

Aylin Yaman1, Zeynep Ozbek, Ali Osman Saatci, Ismet Durak, Banu Lebe.   

Abstract

PURPOSE: To discuss a case of Churg-Strauss syndrome that developed bilateral conjunctival involvement while recovering from miliary tuberculosis.
METHODS: Case report and literature review.
RESULTS: A 22-year-old man who was on oral prednisolone for Churg-Strauss syndrome since 2002 contracted miliary tuberculosis in June 2004. The diagnosis was confirmed by liver biopsy. Ophthalmologic examination was within reference limits except for bilateral multifocal choroiditis. A combined therapy of rifampicin, ethambutol, streptomycin, and morphazinamide was started on June 24, 2004. Complete recovery was achieved, and the antituberculosis therapy was terminated in June 2005. The patient noted redness and pain in both eyes a month later. He had bilateral irregular, pink-yellow, gravel-like infiltrations involving the bulbar conjunctiva. Biopsy revealed granulomas with central fibrinoid necrosis, histiocytes, and eosinophils, suggestive of conjunctival involvement of Churg-Strauss syndrome. Topical dexamethasone 0.1% drops were started 4 times per day and tapered gradually. Lesions totally regressed within 2 months. No recurrence was noted during a follow-up of 11 months.
CONCLUSIONS: Churg-Strauss syndrome may rarely involve the conjunctiva, and conjunctival lesions respond favorably to topical steroids.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457205     DOI: 10.1097/ICO.0b013e3180315a93

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  1 in total

Review 1.  [Ocular manifestations of Churg-Strauss syndrome: review article and case report].

Authors:  A Atili; C Richter; E Bahn; H H Rustenbeck; M Schittkowski
Journal:  Ophthalmologe       Date:  2013-11       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.